⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Prescription Weight Loss Medications Market Projected to Reach US$ 40.13 Billion by 2035, Supported by Clinical Adoption and Pipeline Expansion Says Astute Analytica
globenewswire.com
LLY
NVO
AMGN
VTRS
ZTS
REGN
Samsung Epis Holdings publica los resultados financieros del cuarto trimestre y del año fiscal 2025
businesswire.com
AMGN
JNJ
REGN
Samsung Epis Holdings公布2025年第四季及會計年度財務業績
businesswire.com
AMGN
JNJ
REGN
サムスンエピスホールディングス、2025年度第4四半期および通期決算を発表
businesswire.com
AMGN
REGN
JNJ
BIIB
Samsung Epis Holdings公布2025年第四季度及财年财务业绩
businesswire.com
AMGN
REGN
JNJ
BIIB
Samsung Epis Holdings publie ses résultats financiers pour le quatrième trimestre et l’exercice 2025
businesswire.com
AMGN
JNJ
REGN
Samsung Epis Holdings meldet Finanzergebnisse für das vierte Quartal und das Geschäftsjahr 2025
businesswire.com
AMGN
BIIB
GEN
JNJ
REGN
Truveta deepens oncology and scientific leadership with appointment of Johnathan Lancaster, MD, PhD as President and Chief Scientific Officer
globenewswire.com
REGN
MYGN
Samsung Epis Holdings Reports Fourth Quarter and Fiscal Year 2025 Financial Results
businesswire.com
AMGN
JNJ
REGN
BIIB
CD137 Targeted Therapy Research Report 2026-2030: 90 Therapies in Clinical Trials, Upcoming Commercial Launches, Global & Regional Clinical & Commercial Trends,
globenewswire.com
GILD
BMY
REGN
MRK
GENM
ABL
BNTX
BIIB